ABBOTT LABORATORIES - Common Stock (ABT)

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / Common Stock
Shares outstanding
1,740,239,592
Number of holders
1,388
Total 13F shares, excl. options
1,028,753,494
Shares change
+8,630,737
Total reported value, excl. options
$42,786,861,710
Value change
+$362,567,670
Put/Call ratio
92%
Number of buys
558
Number of sells
-633
Price
$41.59

Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q3 2014

1,480 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q3 2014.
ABBOTT LABORATORIES - Common Stock (ABT) has 1,388 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,028,753,494 shares of 1,740,239,592 outstanding shares and own 59% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (86,537,169 shares), State Street Corp (65,118,552 shares), BlackRock Institutional Trust Company, N.A. (39,486,138 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (35,806,719 shares), Bank of New York Mellon Corp (33,776,710 shares), NORTHERN TRUST CORP (23,380,808 shares), JENNISON ASSOCIATES LLC (21,595,050 shares), BlackRock Fund Advisors (18,861,540 shares), JPMORGAN CHASE & CO (18,532,482 shares), and PRIMECAP MANAGEMENT CO/CA/ (17,089,257 shares).
This table shows the top 1,388 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.